Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), the science-focused multi-state cannabis company with active operations in exclusively medical-only markets and licenses in 10 states and the commonwealth of Puerto Rico, today announced that Amy Langer has resigned from the Board of Directors in order to focus on her other business endeavors.
| MINNEAPOLIS, March 16, 2020 /PRNewswire/ -- Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), the science-focused multi-state cannabis company with active operations in exclusively medical-only markets and licenses in 10 states and the commonwealth of Puerto Rico, today announced that Amy Langer has resigned from the Board of Directors in order to focus on her other business endeavors.
“We are grateful to Amy for her contributions as a Board Member,” said Founder & Chief Executive Officer, Kyle Kingsley, M.D. “Amy helped guide us through a time of fast-paced expansion and growth. We thank her for those efforts and wish her the best on all future endeavors.” About Vireo Health International, Inc. Vireo Health International, Inc. is a physician-led cannabis company focused on building long-term, sustainable value by bringing the best of medicine, science, and engineering to the cannabis industry. With operations strategically located in early-stage, limited-license medical markets, Vireo manufactures pharmaceutical-grade cannabis products in environmentally-friendly greenhouses and distributes its products through its growing network of Green Goods™ retail dispensaries and hundreds of third-party locations. Its current core medical markets of New York, Minnesota, Pennsylvania, Arizona, New Mexico, Maryland, Ohio and Rhode Island all have the potential to enact adult-use legalization in the next three to 24 months, and three additional markets in Puerto Rico, Massachusetts and Nevada also have potential for commercialization. Combined with its teams’ focus on driving scientific innovation within the industry and securing meaningful intellectual property, Vireo believes it is well positioned to become a global market leader in the cannabis industry. In aggregate, Vireo’s total license portfolio spans 11 state markets with a total addressable population of over 80 million patients. Today, eight of its 11 state markets are operational with 13 of its 32 total retail dispensary licenses open for business. For more information about the company, please visit www.vireohealth.com. CONTACT: Albert Zakes, (267) 221-4800, albezakes@vireohealth.com
SOURCE Vireo Health International, Inc. | ||
Company Codes: CNSX:VREO, OTC-PINK:VREOF |
View original content to download multimedia:
